The interplay between m6A RNA methylation and noncoding RNA in cancer.

Area of Science:

• Epigenetics
• Molecular Biology
• Oncology

Background:

• N6-methyladenosine (m6A) is a prevalent RNA modification impacting biological functions and diseases.
• m6A modification influences cancer progression by regulating cellular processes.
• Noncoding RNAs are involved in regulating m6A modifications and cancer-related functions.

Purpose of the Study:

• To review the interplay between m6A modifications and noncoding RNAs in cancer progression.
• To highlight the roles of m6A and noncoding RNAs in cancer biology.
• To discuss their potential as biomarkers and therapeutic targets in cancer treatment.

Main Methods:

• Literature review of studies on m6A methylation and noncoding RNAs in cancer.
• Analysis of the regulatory mechanisms of m6A on noncoding RNAs.
• Examination of the impact of noncoding RNAs on m6A modifications.

Main Results:

• m6A modification affects noncoding RNA metabolism (cleavage, transport, stability, degradation).
• m6A and noncoding RNAs regulate key cancer processes like proliferation, metastasis, stem cell differentiation, and homeostasis.
• The interaction between m6A and noncoding RNAs is crucial for cancer development.

Conclusions:

• The intricate relationship between m6A and noncoding RNAs significantly impacts cancer progression.
• m6A and noncoding RNAs show promise as potential diagnostic biomarkers for cancer.
• Targeting m6A and noncoding RNAs could offer novel therapeutic strategies for cancer treatment.